Prelude Therapeutics Incorporated
USD4.93
+0.55 (+12.56%)
CEO
Krishna Vaddi
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.39
Prev. Close
$4.38
Day Low
$4.35
Day High
$4.99
52W Low
$0.75
52W High
$5.54
Market Cap
$0.28B
Volume
0.47M
| 38,000 |
| $3.94 |
| 10 Jun 2026 | Babler Martin | director | A-Award | Acquired | 38,000 | $3.94 |
| 10 Jun 2026 | Bonita David P | director, 10 percent owner: | A-Award | Acquired | 38,000 | $3.94 |
| 10 Jun 2026 | Sandor Victor | director | A-Award | Acquired | 38,000 | $3.94 |
| 10 Jun 2026 | FRIEDMAN PAUL A | director | A-Award | Acquired | 38,000 | $3.94 |
| 4 May 2026 | Morris Charles Q | Chief Medical Officer | A-Award | Acquired | 450,000 | $4.70 |
| 28 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | J-Other | Disposed | 1,407,000 | $0.00 |
| 28 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | J-Other | Acquired | 1,407,000 | $0.00 |
| 28 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Disposed | 0 | $0.00 |